China’s Zhejiang Jingxing Paper Joint Stock Co. has responded to customer demand for high-quality tissue products by investing in two Valmet-supplied Advantage DCT 200 HS tissue lines.
The scope of supply includes an automation system and three tissue rewinders for a planned start-up in the first half of 2022.
Once up and running, the new lines will increase the company’s production capacity by 120,000tpy and will support the increasing demand for high-quality tissue products in the domestic and international markets.
TM5 and TM6 will have a width of 5.6m and a design speed of 2,000m/min and will be equipped with OptiFlo headbox and steel Yankee cylinders.
The value of the order was not disclosed but a project of this size and scope is typically valued at around €20-30m.